Editor in Chief Dr KK Aggarwal, Padma Shri Awardee Dated:04 April,2020
DRDO develops bio suits for doctors, paramedics engaged in treating coronavirus patients
NEW DELHI: India's premier defence research institution DRDO has developed a "bio suit" to protect doctors and paramedics engaged in treating coronavirus-affected people from the infection.
Incubation period: Evidences on SARS-CoV-2 (COVID-19)
We present to you a series of daily questions related to various aspects of COVID-19, which summarizes what is known and what additional information is needed.
CMAAO Corona Facts and Myth Buster 32
Only testing can decide that I have recoveredMyth: No. , Re-testing method: The CDC has advised that all confirmed and suspected patients should be symptom-free and test negative twice within at least 24 hours to be considered as having recovered. ....read more
Spiritual prescriptions learnt from patients
As doctors, we are witnesses to human suffering. When we were young in medical college, we were quite disturbed seeing the sufferings of the people. But, in our practice, we have learnt many spiritual prescriptions from our patients. These have not only helped us to heal our patients but also changed our perception to health and sickness.
Health Sutras By Dr K K Aggarwal
Do not allow water to collect in and around houses as it could be a breeding place for mosquitos.
Healthcare News Monitor
India Today – PTI
Scientists have found a trial drug that effectively blocks the cellular door Sars-CoV-2 uses to infect its hosts, an advance that they say may provide a potential treatment for the novel coronavirus. The study, published in the journal Cell, provides new insights into key aspects of Sars-CoV-2, the virus that causes Covid-19. It also provides details about the interactions of the virus on a cellular level, as well as how it can infect blood vessels and kidneys. "We are hopeful our results have implications for the development of a novel drug for the treatment of this unprecedented pandemic," said Josef Penninger, from the University of British Columbia in Canada. The researchers said ACE2 -- a protein on the surface of the cell membrane -- is now at centre-stage in this outbreak as the key receptor for the spike glycoprotein of Sars-CoV-2. In earlier work, Penninger and colleagues at the University of Toronto and the Institute of Molecular Biology in Austria found that in living organisms, ACE2 is the key receptor for SARS, the viral respiratory illness recognised as a global threat in 2003.
India Today – PTI
With US President Donald Trump describing hydroxychloroquine as a "game-changer" in the fight against Covid-19 and several countries, including India, approving it for emergencies, pharmacies are reporting a surge in demand for the drug yet to be proven as a cure against the disease. Though there have been no large-scale clinical trials of the drug's efficacy in treating coronavirus, chemists all over say they are facing a shortage of the medicine, not so long ago known mainly to those who had malaria or were prescribed it for arthritis pain. Hydroxychloroquine entered the layperson's lexicon with Trump's tweet on March 21. A few days later, several countries approved it for restricted use in coronavirus emergencies and for certain categories of people only. And while the White House's own infectious disease expert Dr Anthony Fauci countered the claims, adding that the drug's effectiveness was only "anecdotal" and needed controlled clinical trials to prove its effectiveness, Trump's tweets had already had a ripple effect across the globe. "The drug has been out of stock ever since Trump tweeted about it," a pharmacist from New Delhi's Kailash Colony told PTI on the condition of anonymity. He added that efforts are being made to restock the medicines. Asked about the current availability of the drug in the country, a pharmacist in the city's Govindpuri area said the drug has been out of stock in his store for days. He also expressed concern that patients with joint aches and other bone-related conditions are being deprived of the drug, prescribed to them by their doctors.
Bihar: Gaya doctor quarantined for 14 days
The Times of India- Abdul Qadir
A doctor deputed in the Covid-19 ward of the Anugrah Narain Magadh Medical College and Hospital (ANMMCH) has been quarantined for 14 days in a designated hotel in Bodh Gaya. In another development, three of the four corona patients admitted to ANMMCH have been shifted to Nalanda Medical College and Hospital (NMCH), Patna. ANMMCH superintendent Dr Vijay Krishna Prasad confirmed the quarantine of the doctor and shifting of three patients to NMCH, Patna. The patients shifted to Patna are the first three positive cases reported in Gaya. They are from the same family comprising the ward boy of a Patna-based private hospital, a resident of Paharpur area on the southern outskirts of the town. A fourth Covid-19 patient is a woman living in the Gurudwara Road locality, who recently returned from Dubai. Meanwhile, gearing up for any emergency, the district administration, on Friday acquired three Bodh Gaya hotels to notify them as quarantine centres. The hotels are Sidharth International, Hotel Delta and Imperial Hotel. Besides these hotels, Bhutipalo Hospital and Meditation Centre has also been identified as a backup facility to quarantine Covid-19 suspects. Gaya DM Abhishek Singh and SSP Rajiv Mishra on Friday inspected the proposed quarantine centres and directed the hotel management to follow the protocol and ensure that the hotel towels are not used. Meanwhile, one new suspect was admitted to the isolation ward of the ANMMCH. With this, the total number of suspects has gone up to 94. Four of the inmates have tested positive. Report is awaited in respect of 18 isolation ward inmates. The inmates who tested negative have been discharged.
Two nurses working at the Delhi State Cancer Institute were tested positive for coronavirus on Friday. On March 31, a doctor at the same institute had also been tested positive for the coronavirus. Health authorities have started contact tracing of these nurses. After the doctor was tested positive, the hospital had closed its OPD, offices, labs and had carried out a sanitation process for the entire structure. The doctor had no travel history but reportedly got the virus from his brother. These cases are now part of a list of health workers in Delhi who have been infected with coronavirus. A resident doctor from Delhi's All India Institute of Medical Sciences (AIIMS) had tested positive for coronavirus on Thursday. There were also reports of a CRPF doctor placed in Saket, Delhi being tested positive with the coronavirus. On Wednesday, three doctors in Delhi had also tested positive for COVID-19, two of them are from Safdarjung Hospital. The third doctor works at Sadar Vallabh Bhai Patel Hospital. Less than ten days ago, two mohalla clinic doctors were also tested positive for coronavirus. The wife and daughter of one the mohalla clinic doctors were also tested positive for COVID-19. The Delhi government had issued a notice for all people who had visited the mohalla clinics to self-quarantine themselves and report at once if they displayed any symptoms.